Vanguard Group Inc Sarepta Therapeutics, Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 9,085,456 shares of SRPT stock, worth $580 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
9,085,456
Previous 8,967,552
1.31%
Holding current value
$580 Million
Previous $1.12 Billion
1.37%
% of portfolio
0.02%
Previous 0.02%
Shares
15 transactions
Others Institutions Holding SRPT
# of Institutions
532Shares Held
85.3MCall Options Held
1.55MPut Options Held
1.35M-
Black Rock Inc. New York, NY10.3MShares$659 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA8.7MShares$555 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$276 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$260 Million0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.87MShares$183 Million1.85% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $5.59B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...